cancer, ecology, genetics & genomics
A Malignant Alliance
Megan Scudellari | Apr 1, 2012
Two proteins interact to save adhesion molecules from degradation, potentially contributing to a more aggressive cancer.
Agents Provocateurs
Mary Beth Aberlin | Apr 1, 2012
Asking pointed questions is a key part of the scientific process.
The Scientist Staff | Apr 1, 2012
Meet some of the people featured in the April 2012 issue of The Scientist.
Are Cancer Stem Cells Ready for Prime Time?
Are Cancer Stem Cells Ready for Prime Time?
Suling Liu, Hasan Korkaya, and Max S. Wicha | Apr 1, 2012
A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.
Finding Phenotypes
Edyta Zielinska | Apr 1, 2012
Genes shared across species that produce different phenotypes – deafness in humans and directional growth in plants – may reveal new models of disease.
Whirlpool Bistros
Edyta Zielinska | Apr 1, 2012
Fish adapt to feed for months along the entire depth of massive oceanic whirlpools that are rich in nutrients and plankton.
Speaking of Science
The Scientist Staff | Apr 1, 2012
April 2012's selection of notable quotes
Eyes on Cancer
Amber Dance | Apr 1, 2012
Techniques for watching tumors do their thing
Pesticide Problems for Bees
Pesticide Problems for Bees
Sabrina Richards | Mar 30, 2012
Bees exposed to neonicotinoids, a widely-used class of pesticide, navigate poorly and produce fewer queens, suggesting a role for neonicotinoids in colony collapse.
Failed Drugs Expose Preclinical Blunders
Megan Scudellari | Mar 30, 2012
Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.